Alpha 2.0
Login Register
» Articles » PMID: 38710833

Urgent Action is Needed to Confront Artemisinin Partial Resistance in African Malaria Parasites

Overview
Journal Nat Med
Specialties General Medicine
Molecular Biology
Date 2024 May 6
PMID 38710833
Authors
Deus S Ishengoma
Roly Gosling
Rosario Martinez-Vega
Khalid B Beshir
Jeffrey A Bailey
John Chimumbwa
Colin Sutherland
Melissa D Conrad
Fitsum G Tadesse
Jonathan J Juliano
Moses R Kamya
Wilfred F Mbacham
Didier Menard
Philip J Rosenthal
Jaishree Raman
Allison Tatarsky
Sofonias K Tessema
David A Fidock
Abdoulaye A Djimde
Affiliations
Soon will be listed here.
Citing Articles

Low prevalence of copy number variation in pfmdr1 and pfpm2 in Plasmodium falciparum isolates from southern Angola.

Duarte D, Manuel F, Dias A, Sacato E, Taleingue E, Daniel E Malar J. 2025; 24(1):5.

PMID: 39794826 PMC: 11720348. DOI: 10.1186/s12936-024-05240-2.

Regional action needed to halt antimalarial drug resistance in Africa.

Martinez-Vega R, Ishengoma D, Gosling R, Rosenthal P, Dondorp A, Barnes K Lancet. 2024; 405(10472):7-10.

PMID: 39674185 PMC: 11838165. DOI: 10.1016/S0140-6736(24)02706-5.

Tambjamines as Fast-Acting Multistage Antimalarials.

Kumar A, Li Y, Dodean R, Roth A, Caridha D, Madejczyk M ACS Infect Dis. 2024; 10(12):4291-4300.

PMID: 39526703 PMC: 11645189. DOI: 10.1021/acsinfecdis.4c00659.

Optimization of B-Ring-Functionalized Antimalarial Tambjamines and Prodiginines.

Kumar A, Chithanna S, Li Y, Zhang X, Dodean R, Caridha D J Med Chem. 2024; 67(21):19755-19776.

PMID: 39425665 PMC: 11563898. DOI: 10.1021/acs.jmedchem.4c02093.

Artemisinin-resistant malaria.

White N, Chotivanich K Clin Microbiol Rev. 2024; 37(4):e0010924.

PMID: 39404268 PMC: 11629630. DOI: 10.1128/cmr.00109-24.

References
1.
Imwong M, Suwannasin K, Kunasol C, Sutawong K, Mayxay M, Rekol H . The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study. Lancet Infect Dis. 2017; 17(5):491-497. PMC: 5406483. DOI: 10.1016/S1473-3099(17)30048-8. View
2.
Dhorda M, Amaratunga C, Dondorp A . Artemisinin and multidrug-resistant Plasmodium falciparum - a threat for malaria control and elimination. Curr Opin Infect Dis. 2021; 34(5):432-439. PMC: 8452334. DOI: 10.1097/QCO.0000000000000766. View
3.
Emiru T, Getachew D, Murphy M, Sedda L, Ejigu L, Bulto M . Evidence for a role of Anopheles stephensi in the spread of drug- and diagnosis-resistant malaria in Africa. Nat Med. 2023; 29(12):3203-3211. PMC: 10719088. DOI: 10.1038/s41591-023-02641-9. View
4.
Adam M, Nahzat S, Kakar Q, Assada M, Witkowski B, Tag Eldin Elshafie A . Antimalarial drug efficacy and resistance in malaria-endemic countries in HANMAT-PIAM_net countries of the Eastern Mediterranean Region 2016-2020: Clinical and genetic studies. Trop Med Int Health. 2023; 28(10):817-829. DOI: 10.1111/tmi.13929. View
5.
Tumwebaze P, Conrad M, Okitwi M, Orena S, Byaruhanga O, Katairo T . Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda. Nat Commun. 2022; 13(1):6353. PMC: 9605985. DOI: 10.1038/s41467-022-33873-x. View